Nimotop Tablets 30mg 100s contain nimodipine 30mg per film-coated tablet. Nimodipine belongs to a group of medicines known as calcium channel blockers, specifically dihydropyridine calcium antagonists. It has a particular effect on blood vessels supplying the brain.
Nimotop is a prescription medicine used specifically in the management of patients following aneurysmal subarachnoid haemorrhage, where it is indicated for the prevention of ischaemic neurological deficits caused by reduced blood flow to the brain.
USES / INDICATIONS
Nimotop 30mg is indicated for:
- Prevention of ischaemic neurological deficits following aneurysmal subarachnoid haemorrhage
PRECAUTIONS & WARNINGS
- Prescription-only medicine.
- Use only under specialist medical supervision.
- Use cautiously in patients with low blood pressure.
- Dose adjustment or close monitoring may be required in severe liver impairment.
- Inform the doctor about all medicines being taken.
- Avoid grapefruit juice.
- Do not combine with rifampicin, phenobarbital, phenytoin or carbamazepine unless specifically directed by a specialist; these combinations are contraindicated according to the product information.
- Do not use in patients with hypersensitivity to nimodipine or its ingredients.
- Do not use during or within one month of myocardial infarction or an episode of unstable angina.
- Seek medical attention if significant dizziness, fainting or symptoms associated with very low blood pressure occur.
COMMON SIDE EFFECTS
Possible adverse effects of nimodipine include:
- Headache
- Dizziness
- Low blood pressure
- Nausea
- Gastrointestinal discomfort
- Rash
- Flushing
- Sweating
- Peripheral oedema
- Palpitations or changes in heart rate
Because Nimotop can lower blood pressure, patients receiving it require appropriate clinical monitoring.
